World's Best Scientists 2026 revealed!
Oscar S. Gershanik

Oscar S. Gershanik

D-Index & Metrics

Neuroscience

D-Index
41
Citations
7359
World Ranking
7825
National Ranking
17

Oscar S. Gershanik publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Oscar S. Gershanik sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 107 publications — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Oscar S. Gershanik D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Oscar S. Gershanik sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 41 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Oscar S. Gershanik is affiliated with Favaloro University in Argentina, contributing extensively to the fields of medicine and neuroscience. Their research predominantly focuses on neurology, particularly addressing neurological disorders and treatments, with a significant emphasis on Parkinson's disease mechanisms and treatments. Additional subfields include cellular and molecular neuroscience, cognitive neuroscience, endocrinology, diabetes and metabolism, and molecular biology.

Their recent scholarly output includes publications in various reputable venues. Notable papers include:

  • "Six Action Steps to Address Global Disparities in Parkinson Disease," 2022, JAMA Neurology
  • "A Statement of the MDS on Biological Definition, Staging, and Classification of Parkinson's Disease," 2023, Movement Disorders
  • "Fyn Knock-Down Prevents Levodopa-Induced Dyskinesia in a Mouse Model of Parkinson's Disease," 2021, eNeuro
  • "Six Action Steps to Address Global Disparities in Parkinson Disease: A World Health Organization (WHO) Priority," 2022, SSRN Electronic Journal
  • "Unanswered Questions in Clinical Practice," 2023, Movement Disorders Clinical Practice

Frequent co-authors in their work include:

  • Michael S. Okun
  • Bastiaan R. Bloem
  • Victor S.C. Fung
  • Shen-Yang Lim
  • Njideka Okubadejo

Oscar S. Gershanik's publications are frequently found in these scientific journals and venues:

  • JAMA Neurology
  • Movement Disorders
  • eNeuro
  • SSRN Electronic Journal
  • Movement Disorders Clinical Practice

The scientist's main research topics focus on:

  • Neurological disorders and treatments
  • Parkinson's Disease Mechanisms and Treatments
  • Autism Spectrum Disorder Research
  • Neurological diseases and metabolism
  • Nuclear Receptors and Signaling
  • Genetic Neurodegenerative Diseases
  • Autoimmune Neurological Disorders and Treatments

Best Publications

  • Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine

    Marcelo Rubinstein;Tamara J. Phillips;Tamara J. Phillips;James R. Bunzow;Tomás L. Falzone

  • Postural deformities in Parkinson's disease

    Karen M Doherty;Bart P van de Warrenburg;Maria Cecilia Peralta;Laura Silveira-Moriyama

  • Levodopa in the treatment of Parkinson's disease: current controversies.

    C. Warren Olanow;Yves Agid;Yoshi Mizuno;Alberto Albanese

  • Early Treatment of Parkinson’s Disease with Cabergoline Delays the Onset of Motor Complications

    U. K. Rinne;F. Bracco;C. Chouza;E. Dupont

  • Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions

    M G Murer;G Dziewczapolski;L B Menalled;M C García

  • Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification.

    M. R. Luquin;O. Scipioni;J. Vaamonde;O. Gershanik

  • Expanded and independent validation of the Movement Disorder Society–Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)

    Pablo Martinez-Martin;Carmen Rodriguez-Blazquez;Mario Alvarez-Sanchez;Tomoko Arakaki

  • Behavioral correlations of dopamine receptor activation

    Oscar Gershanik;Richard E. Heikkila;Roger C. Duvoisin

  • The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.

    Fulvio Bracco;Angelo Battaglia;Carlos Chouza;Erik Dupont

  • Motor-language coupling: direct evidence from early Parkinson's disease and intracranial cortical recordings.

    Agustín Ibáñez;Agustín Ibáñez;Agustín Ibáñez;Juan F. Cardona;Juan F. Cardona;Juan F. Cardona;Yamil Vidal Dos Santos;Yamil Vidal Dos Santos;Alejandro Blenkmann

  • Action-verb processing in Parkinson’s disease: new pathways for motor–language coupling

    Juan Felipe Cardona;Oscar Gershanik;Oscar Gershanik;Carlos Gelormini-Lezama;Carlos Gelormini-Lezama;Alexander Lee Houck

  • Cabergoline in the treatment of early parkinson's disease: Results of the first year of treatment in a double-blind comparison of cabergoline and levodopa

    U. K. Rinne;F. Bracco;C. Chouza;E. Dupont

  • Six Action Steps to Address Global Disparities in Parkinson Disease: A World Health Organization Priority.

    Unknown

  • Impairments in social cognition in early medicated and unmedicated Parkinson disease.

    María Roca;Teresa Torralva;Ezequiel Gleichgerrcht;Anabel Chade

  • Levodopa in the treatment of Parkinson's disease: a consensus meeting.

    Y. Agid;E. Ahlskog;A. Albanese;D. Calne

  • Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale

    P. Martinez-Martin;K. R. Chaudhuri;J. M. Rojo-Abuin;C. Rodriguez-Blazquez

  • Neuropsychological disturbances in hemiparkinson's disease

    Sergio Starkstein;Ramon Leiguarda;Oscar Gershanik;Marcelo Berthier

  • Polysomnographic measures in Parkinson's disease: a comparison between patients with and without REM sleep disturbances.

    T C Wetter;C Trenkwalder;O Gershanik;B Högl

  • A clinical, pharmacologic, and polysomnographic study of sleep benefit in Parkinson's disease

    B E Högl;G Gómez-Arévalo;S García;O Scipioni

  • Treatable inherited rare movement disorders

    H. A. Jinnah;Alberto Albanese;Kailash P. Bhatia;Francisco Cardoso

  • How embodied is action language? Neurological evidence from motor diseases

    Juan F. Cardona;Juan F. Cardona;Juan F. Cardona;Lucila Kargieman;Lucila Kargieman;Vladimiro Sinay;Oscar Gershanik;Oscar Gershanik

Frequent Co-Authors

Facundo Manes
Facundo Manes Favaloro University
Agustín Ibáñez
Agustín Ibáñez Adolfo Ibáñez University
Rita Raisman-Vozari
Rita Raisman-Vozari Université Paris Cité
Marcelo Rubinstein
Marcelo Rubinstein University of Buenos Aires
Christopher G. Goetz
Christopher G. Goetz Rush University Medical Center
Pablo Martinez-Martin
Pablo Martinez-Martin Instituto de Salud Carlos III
Glenn T. Stebbins
Glenn T. Stebbins Rush University Medical Center
Barbara C. Tilley
Barbara C. Tilley The University of Texas Health Science Center at Houston
Adolfo M. García
Adolfo M. García University of San Andrés
Sandra Baez
Sandra Baez Universidad de Los Andes

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As you explore studying Neuroscience in the USA, it’s worth considering a variety of online degrees and career pathways that can complement or enhance your expertise. For students seeking flexibility, accelerated online degrees offer a fast-track route to earning your credentials, letting you graduate and enter the workforce sooner without sacrificing academic rigor.

Neuroscience majors often intersect with high-demand fields. According to data on the highest earning degrees and the most lucrative college degrees, areas such as biomedical engineering, information technology, and health sciences can open doors to rewarding careers and higher earning potential.

Cost is another key factor. Many online colleges that accept financial aid can help reduce your financial burden, making advanced education more accessible. No matter your path, explore programs that align with your personal goals, budget, and long-term career aspirations.

Best Scientists Citing Oscar S. Gershanik

Trending Scientists

Recently Published Articles